ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Pfizer Inks Deal For Space At MIT

by Michael McCoy
September 12, 2011 | APPEARED IN VOLUME 89, ISSUE 37

Pfizer has signed a 10-year lease on 180,000 sq ft of space in a building being constructed in Cambridge, Mass., by Massachusetts Institute of Technology. To open in 2013, the building will house close to 400 employees of two Pfizer research units: cardiovascular, metabolic, and endocrine disease; and neuroscience. The drug giant said earlier this year that the units will relocate from Groton, Conn. Rod MacKenzie, the firm’s head of pharmatherapeutics R&D, anticipates collaboration between scientists from local institutions and Pfizer’s researchers.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment